Amgen Inc. (AMGN)
NASDAQ
Closed
Sep 4, 2026
Day's Range
435.0052 wk Range
269.77Overview - AMGN - Amgen Inc.
Key Statistics
Valuation
Enterprise Value
283.42B
P/E (Trailing)
‪27.46‬
P/E (Forward)
‪18.20‬
PEG Ratio
‪0.41‬
Price / Sales (TTM)
‪6.30‬
Price / Book
‪20.54‬
EV / EBITDA
‪16.41‬
Profitability
Gross Margin
‪72.04%‬
Profit Margin
‪22.95%‬
Operating Margin
‪35.54%‬
Return on Assets
‪8.66%‬
Return on Equity
‪91.47%‬
Ownership
Shares Outstanding
541.00M
Float
539.16M
Short % of Shares Outstanding
‪2.23%‬
Held by Insiders
‪0.22%‬
Held by Institutions
‪85.13%‬
Price stats
Beta
‪0.41‬
50-Day Avg
‪393.52‬
200-Day Avg
‪357.43‬
Dividends
Payout Ratio
‪60.87%‬
Frequency
Quarterly
Analyst Consensus
34 analysts
Average price target
‪$ 388.48‬Shariah Compliance
Report Date: Feb 19, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - AMGN - Amgen Inc.
Peers - AMGN - Amgen Inc.
Peer Comparison
Compared with companies in Drug Manufacturers - General listed on NASDAQ.
- AMGNNASDAQAmgen Inc.236.38BMarket Cap+35.92%52-week change27.47P/E (Trailing)‪22.95%‬Profit Margin
- AZNNASDAQAstraZeneca PLC American Depositary Shares252.33BMarket Cap-0.26%52-week change24.60P/E (Trailing)‪17.02%‬Profit Margin
- GILDNASDAQGilead Sciences, Inc.180.63BMarket Cap+22.63%52-week change17.87P/E (Trailing)‪-10.63%‬Profit Margin
- SNYNASDAQSanofi ADR106.00BMarket Cap-5.79%52-week change23.71P/E (Trailing)‪8.09%‬Profit Margin
- ROPNASDAQRoper Technologies Inc.42.15BMarket Cap-23.49%52-week change17.60P/E (Trailing)‪30.24%‬Profit Margin
- BIIBNASDAQBiogen Inc32.62BMarket Cap+35.99%52-week change39.53P/E (Trailing)‪8.32%‬Profit Margin
- GRFSNASDAQGrifols S.A. ADR5.36BMarket Cap-28.55%52-week change10.23P/E (Trailing)‪6.09%‬Profit Margin
Profile Summary - AMGN - Amgen Inc.
About
Amgen Inc. is a global biotechnology company that develops, manufactures, and commercializes human therapeutics for serious diseases. Its portfolio centers on biologic medicines and specialty therapies used in oncology, inflammation, cardiovascular disease, bone health, nephrology, and rare diseases. The company also…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
